Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response.

Maseda D, Zackular JP, Trindade B, Kirk L, Roxas JL, Rogers LM, Washington MK, Du L, Koyama T, Viswanathan VK, Vedantam G, Schloss PD, Crofford LJ, Skaar EP, Aronoff DM.

MBio. 2019 Jan 8;10(1). pii: e02282-18. doi: 10.1128/mBio.02282-18.

2.

An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection.

Vedantam G, Kochanowsky J, Lindsey J, Mallozzi M, Roxas JL, Adamson C, Anwar F, Clark A, Claus-Walker R, Mansoor A, McQuade R, Monasky RC, Ramamurthy S, Roxas B, Viswanathan VK.

Front Microbiol. 2018 Sep 5;9:2080. doi: 10.3389/fmicb.2018.02080. eCollection 2018.

3.

Epithelial maturity influences EPEC-induced desmosomal alterations.

Roxas JL, Vedantam G, Viswanathan VK.

Gut Microbes. 2018 Sep 5:1-5. doi: 10.1080/19490976.2018.1506669. [Epub ahead of print]

PMID:
30183504
4.

Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations.

Roxas JL, Monasky RC, Roxas BAP, Agellon AB, Mansoor A, Kaper JB, Vedantam G, Viswanathan VK.

Cell Mol Gastroenterol Hepatol. 2018 Apr 27;6(2):163-180. doi: 10.1016/j.jcmgh.2018.04.007. eCollection 2018.

5.

Modulation of Intestinal Paracellular Transport by Bacterial Pathogens.

Roxas JL, Viswanathan VK.

Compr Physiol. 2018 Mar 25;8(2):823-842. doi: 10.1002/cphy.c170034.

PMID:
29687905
6.

Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

Roxas JL, Ryan K, Vedantam G, Viswanathan VK.

Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G374-80. doi: 10.1152/ajpgi.00312.2013. Epub 2014 Jun 5.

7.

Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile.

Merrigan MM, Venugopal A, Roxas JL, Anwar F, Mallozzi MJ, Roxas BA, Gerding DN, Viswanathan VK, Vedantam G.

PLoS One. 2013 Nov 12;8(11):e78404. doi: 10.1371/journal.pone.0078404. eCollection 2013.

8.

The enteropathogenic Escherichia coli-secreted protein EspZ inhibits host cell apoptosis.

Roxas JL, Wilbur JS, Zhang X, Martinez G, Vedantam G, Viswanathan VK.

Infect Immun. 2012 Nov;80(11):3850-7. doi: 10.1128/IAI.00335-12. Epub 2012 Aug 20.

9.

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.

Royan SV, Jones RM, Koutsouris A, Roxas JL, Falzari K, Weflen AW, Kim A, Bellmeyer A, Turner JR, Neish AS, Rhee KJ, Viswanathan VK, Hecht GA.

Mol Microbiol. 2010 Dec;78(5):1232-45. doi: 10.1111/j.1365-2958.2010.07400.x. Epub 2010 Oct 15.

10.

Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner.

Roxas JL, Koutsouris A, Bellmeyer A, Tesfay S, Royan S, Falzari K, Harris A, Cheng H, Rhee KJ, Hecht G.

Lab Invest. 2010 Aug;90(8):1152-68. doi: 10.1038/labinvest.2010.91. Epub 2010 May 17.

11.

Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.

Viswanathan VK, Weflen A, Koutsouris A, Roxas JL, Hecht G.

Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1165-70. doi: 10.1152/ajpgi.00596.2007. Epub 2008 Mar 20.

12.

Supplemental Content

Loading ...
Support Center